XML 34 R27.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Mar. 28, 2022
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Summary of Significant Accounting Policies [Line Items]            
Percentage of direct billing channel revenue insures represent   27.00% 53.00% 35.00% 57.00%  
Revenue   $ 7,520,767 $ 5,958,544 $ 11,275,156 $ 9,405,252  
Deferred revenue   12,000   12,000   $ 8,500
Cost of goods sold   121,800 265,600 144,600 366,800  
Advertising expense   849,600 846,400 1,636,900 1,537,900  
Restructuring Reserve, Foreign Currency Translation Gain (Loss)   $ 9,200 $ 71,400 $ 52,400 $ 5,600  
Warrants exercise price   $ 0.0001   $ 0.0001    
Common stock equivalents, pre-funded warrants   7,721,519 6,830,926 7,721,519 6,830,926  
Short-Term Investments   $ 3,135,800   $ 3,135,800   $ 1,994,700
Product Revenue [Member] | Geographic Concentration Risk [Member] | United States [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage   86.00% 63.00% 82.00% 70.00%  
Product Revenue [Member] | Geographic Concentration Risk [Member] | China [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage     29.00%   18.00%  
Product Revenue [Member] | Geographic Concentration Risk [Member] | Germany [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage   14.00% 8.00% 17.00% 11.00%  
Product Revenue [Member] | Geographic Concentration Risk [Member] | Other International Locations [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage       1.00% 1.00%  
Beijing Ryzur Medical Investment Co., Ltd            
Summary of Significant Accounting Policies [Line Items]            
Upfront license fee       $ 2,700,000    
License revenue            
Summary of Significant Accounting Policies [Line Items]            
Revenue   $ 0 $ 1,714,920 0 $ 1,714,920  
License revenue | Product Revenue [Member] | Geographic Concentration Risk [Member] | United States [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage         85.00%  
License revenue | Product Revenue [Member] | Geographic Concentration Risk [Member] | Germany [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage         14.00%  
License revenue | Product Revenue [Member] | Geographic Concentration Risk [Member] | Other International Locations [Member]            
Summary of Significant Accounting Policies [Line Items]            
Concentration Risk, Percentage         1.00%  
O&P Providers or Third Party Payors [Member]            
Summary of Significant Accounting Policies [Line Items]            
Revenue recognized   $ 1,865,800 $ 403,900 $ 1,745,000 $ 1,898,200  
Jiangxi Myomo Medical Assistive Appliance Co. Ltd            
Summary of Significant Accounting Policies [Line Items]            
Cash consideration paid $ 199,000          
Ownership percentage 19.90%